Silvercrest Asset Management’s BridgeBio Pharma BBIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-256,756
| Closed | -$2.61M | – | 813 |
|
|
2022
Q1 | $2.61M | Buy |
256,756
+3,030
| +1% | +$30.8K | 0.02% | 464 |
|
|
2021
Q4 | $4.23M | Buy |
253,726
+179,992
| +244% | +$3M | 0.03% | 405 |
|
|
2021
Q3 | $3.46M | Buy |
73,734
+27,425
| +59% | +$1.29M | 0.02% | 428 |
|
|
2021
Q2 | $2.82M | Buy |
46,309
+1,061
| +2% | +$64.7K | 0.02% | 454 |
|
|
2021
Q1 | $2.79M | Sell |
45,248
-35,422
| -44% | -$2.18M | 0.02% | 450 |
|
|
2020
Q4 | $5.74M | Sell |
80,670
-12,872
| -14% | -$915K | 0.04% | 345 |
|
|
2020
Q3 | $3.51M | Buy |
+93,542
| New | +$3.51M | 0.03% | 391 |
|